Role of obesity-associated dysfunctional adipose tissue in cancer: A molecular nutrition approach

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1807, Issue 6, 2011, Pages 664-678

  Prieto Hontoria, Pedro L ^a   Pérez Matute, Patricia ^b   Fernández Galilea, Marta ^a   Bustos, Matilde ^c   Martínez, J Alfredo ^a   Moreno Aliaga, María J ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b CENTER FOR BIOMEDICAL RESEARCH OF LA RIOJA CIBIR   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Adipokine; Adipose tissue; Cancer; Dietary bioactive factor; Mitochondrial biogenesis; Nutrigenomics; Obesity

Indexed keywords

ADIPONECTIN; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CONJUGATED LINOLEIC ACID; ESTRADIOL; FATTY ACID; INTERLEUKIN 6; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OMEGA 3 FATTY ACID; RESVERATROL; RETINOL; SERINE PROTEINASE INHIBITOR; TESTOSTERONE; THIOCTIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; BREAST CANCER; CANCER RISK; COLORECTAL CANCER; DIETARY INTAKE; ENDOMETRIUM CANCER; ENERGY BALANCE; ENERGY METABOLISM; ESOPHAGUS CANCER; HUMAN; INSULIN RESISTANCE; LIVER CANCER; MITOCHONDRION; MOLECULAR BIOLOGY; NEOPLASM; NUTRIGENOMICS; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; WEIGHT REDUCTION;

ADIPOSE TISSUE; ANIMALS; ENERGY METABOLISM; FOOD; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL; NEOPLASMS; NUTRIGENOMICS; OBESITY;

EID: 79955604487     PISSN: 00052728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbabio.2010.11.004     Document Type: Review

References (248)

1. B.M. Spiegelman, and J.S. Flier Obesity and the regulation of energy balance Cell 104 2001 531 543 (Pubitemid 32201948)
2. A.M. Fair, and K. Montgomery Energy balance, physical activity, and cancer risk Meth. Mol. Biol. 472 2009 57 88
3. M.J. Moreno-Aliaga, J.L. Santos, A. Marti, and J.A. Martinez Does weight loss prognosis depend on genetic make-up? Obes. Rev. 6 2005 155 168 (Pubitemid 40604424)
4. A.G. Comuzzie, and D.B. Allison The search for human obesity genes Science 280 1998 1374 1377 (Pubitemid 28264818)
5. E.E. Calle, and R. Kaaks Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms Nat. Rev. Cancer 4 2004 579 591 (Pubitemid 39025053)
6. E.E. Calle, and M.J. Thun Obesity and cancer Oncogene 23 2004 6365 6378 (Pubitemid 39265505)
7. World Health Organization Obesity and Overweight http://www.who.int/ mediacentre/factsheets/fs311/en/index.html 2006
8. R. Huxley, S. Mendis, E. Zheleznyakov, S. Reddy, and J. Chan Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk-a review of the literature Eur. J. Clin. Nutr. 64 2010 16 22
9. A.H. Mokdad, E.S. Ford, B.A. Bowman, W.H. Dietz, F. Vinicor, V.S. Bales, and J.S. Marks Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001 Jama 289 2003 76 79 (Pubitemid 36026281)
10. J.P. Crandall, W.C. Knowler, S.E. Kahn, D. Marrero, J.C. Florez, G.A. Bray, S.M. Haffner, M. Hoskin, and D.M. Nathan The prevention of type 2 diabetes Nat. Clin. Pract. Endocrinol. Metab. 4 2008 382 393 (Pubitemid 351881862)
11. T. Pischon, U. Nothlings, and H. Boeing Obesity and cancer Proc. Nutr. Soc. 67 2008 128 145 (Pubitemid 351543395)
12. T. Farhat, R.J. Iannotti, and B.G. Simons-Morton Overweight, obesity, youth, and health-risk behaviors Am. J. Prev. Med. 38 2010 258 267
13. W. Gade, J. Schmit, M. Collins, and J. Gade Beyond obesity: the diagnosis and pathophysiology of metabolic syndrome Clin. Lab. Sci. 23 2010 51 61 quiz 62-55
14. P. Mathieu, I. Lemieux, and J.P. Despres Obesity, inflammation, and cardiovascular risk Clin. Pharmacol. Ther. 87 2010 407 416
15. L.R. Kurukulasuriya, S. Stas, G. Lastra, C. Manrique, and J.R. Sowers Hypertension in obesity Endocrinol. Metab. Clin. North Am. 37 2008 647 662 ix.
16. M.K. Ohman, A.P. Wright, K.J. Wickenheiser, W. Luo, and D.T. Eitzman Visceral adipose tissue and atherosclerosis Curr. Vasc. Pharmacol. 7 2009 169 179
17. P. Mathieu, P. Poirier, P. Pibarot, I. Lemieux, and J.P. Despres Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease Hypertension 53 2009 577 584
18. H.N. Ginsberg, and P.R. MacCallum The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus J. Cardiometab. Syndr. 4 2009 113 119
19. J.P. Ong, and Z.M. Younossi Epidemiology and natural history of NAFLD and NASH Clin. Liver Dis. 11 2007 1 16 vii (Pubitemid 46829973)
20. G.C. Farrell, and C.Z. Larter Nonalcoholic fatty liver disease: from steatosis to cirrhosis Hepatology 43 2006 S99 S112
21. D.M. Torres, and S.A. Harrison Diagnosis and therapy of nonalcoholic steatohepatitis Gastroenterology 134 2008 1682 1698 (Pubitemid 351615413)
22. P. Angulo Nonalcoholic fatty liver disease N. Engl. J. Med. 346 2002 1221 1231
23. L.A. Adams, A. Feldstein, K.D. Lindor, and P. Angulo Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction Hepatology 39 2004 909 914 (Pubitemid 38428928)
24. L.A. Adams, S. Sanderson, K.D. Lindor, and P. Angulo The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies J. Hepatol. 42 2005 132 138 (Pubitemid 40038911)
25. L.A. Adams, J.F. Lymp, J. St Sauver, S.O. Sanderson, K.D. Lindor, A. Feldstein, and P. Angulo The natural history of nonalcoholic fatty liver disease: a population-based cohort study Gastroenterology 129 2005 113 121 (Pubitemid 41002048)
26. H.M. Patton, C. Sirlin, C. Behling, M. Middleton, J.B. Schwimmer, and J.E. Lavine Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research J. Pediatr. Gastroenterol. Nutr. 43 2006 413 427 (Pubitemid 44568999)
27. C. Denzer, D. Thiere, R. Muche, W. Koenig, H. Mayer, W. Kratzer, and M. Wabitsch Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance J. Clin. Endocrinol. Metab. 94 2009 3872 3881
28. A. Romero-Corral, S.M. Caples, F. Lopez-Jimenez, and V.K. Somers Interactions between obesity and obstructive sleep apnea: implications for treatment Chest 137 2010 711 719
29. K. Candiotti, S. Sharma, and R. Shankar Obesity, obstructive sleep apnoea, and diabetes mellitus: anaesthetic implications Br. J. Anaesth. 103 Suppl 1 2009 i23 30
30. E. Tasali, B. Mokhlesi, and E. Van Cauter Obstructive sleep apnea and type 2 diabetes: interacting epidemics Chest 133 2008 496 506 (Pubitemid 351272411)
31. L.K. Forsythe, J.M. Wallace, and M.B. Livingstone Obesity and inflammation: the effects of weight loss Nutr. Res. Rev. 21 2008 117 133
32. C.L. Donohoe, G.P. Pidgeon, J. Lysaght, and J.V. Reynolds Obesity and gastrointestinal cancer Br. J. Surg. 97 2010 628 642
33. E.M. Siegel, C.M. Ulrich, E.M. Poole, R.S. Holmes, P.B. Jacobsen, and D. Shibata The effects of obesity and obesity-related conditions on colorectal cancer prognosis Cancer Control 17 2010 52 57
34. B. Teucher, S. Rohrmann, and R. Kaaks Obesity: focus on all-cause mortality and cancer Maturitas 65 2010 112 116
35. R. Percik, and M. Stumvoll Obesity and cancer Exp. Clin. Endocrinol. Diabetes 117 2009 563 566
36. O. Warburg On the origin of cancer cells Science 123 1956 309 314
37. IARC IARC Handbooks of Cancer Prevention Weight control and physical activity 2002
38. M.L. Slattery, K. Curtin, R.K. Wolff, J.S. Herrick, B.J. Caan, and W. Samowitz Diet, physical activity, and body size associations with rectal tumor mutations and epigenetic changes Cancer Causes Control 8 2010 1237 1245
39. A. Maccio, C. Madeddu, G. Gramignano, C. Mulas, C. Floris, D. Massa, G. Astara, P. Chessa, and G. Mantovani Correlation of body mass index and leptin with tumor size and stage of disease in hormone-dependent postmenopausal breast cancer: preliminary results and therapeutic implications J. Mol. Med. 88 2010 677 686
40. E.E. Calle Obesity and cancer BMJ 335 2007 1107 1108 (Pubitemid 350247271)
41. A.S. Anderson, and S. Caswell Obesity management-an opportunity for cancer prevention Surgeon 7 2009 282 285
42. A. Trentham-Dietz, P.A. Newcomb, K.M. Egan, L. Titus-Ernstoff, J.A. Baron, B.E. Storer, M. Stampfer, and W.C. Willett Weight change and risk of postmenopausal breast cancer (United States) Cancer Causes Control 11 2000 533 542 (Pubitemid 30342842)
43. A. Trentham-Dietz, P.A. Newcomb, H.B. Nichols, and J.M. Hampton Breast cancer risk factors and second primary malignancies among women with breast cancer Breast Cancer Res. Treat. 105 2007 195 207 (Pubitemid 47366884)
44. P.H. Lahmann, K. Hoffmann, N. Allen, C.H. van Gils, K.T. Khaw, B. Tehard, F. Berrino, A. Tjonneland, J. Bigaard, A. Olsen, K. Overvad, F. Clavel-Chapelon, G. Nagel, H. Boeing, D. Trichopoulos, G. Economou, G. Bellos, D. Palli, R. Tumino, S. Panico, C. Sacerdote, V. Krogh, P.H. Peeters, H.B. Bueno-de-Mesquita, E. Lund, E. Ardanaz, P. Amiano, G. Pera, J.R. Quiros, C. Martinez, M.J. Tormo, E. Wirfalt, G. Berglund, G. Hallmans, T.J. Key, G. Reeves, S. Bingham, T. Norat, C. Biessy, R. Kaaks, and E. Riboli Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC) Int. J. Cancer 111 2004 762 771 (Pubitemid 39062901)
45. T.J. Key, P.K. Verkasalo, and E. Banks Epidemiology of breast cancer Lancet Oncol. 2 2001 133 140 (Pubitemid 33585924)
46. P. Begum, C.E. Richardson, and A.R. Carmichael Obesity in post menopausal women with a family history of breast cancer: prevalence and risk awareness Int. Semin. Surg. Oncol. 6 2009 1
47. A.R. Carmichael Obesity and prognosis of breast cancer Obes. Rev. 7 2006 333 340 (Pubitemid 44564304)
48. N. Potischman, C.A. Swanson, P. Siiteri, and R.N. Hoover Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status J. Natl Cancer Inst. 88 1996 756 758 (Pubitemid 26195024)
49. M. Harvie, L. Hooper, and A.H. Howell Central obesity and breast cancer risk: a systematic review Obes. Rev. 4 2003 157 173 (Pubitemid 36950578)
50. F. Frasca, G. Pandini, L. Sciacca, V. Pezzino, S. Squatrito, A. Belfiore, and R. Vigneri The role of insulin receptors and IGF-I receptors in cancer and other diseases Arch. Physiol. Biochem. 114 2008 23 37 (Pubitemid 351998752)
51. E.E. Calle, C. Rodriguez, K. Walker-Thurmond, and M.J. Thun Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N. Engl. J. Med. 348 2003 1625 1638 (Pubitemid 36459468)
52. R. Kaaks, A. Lukanova, and M.S. Kurzer Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review Cancer Epidemiol. Biomark. Prev. 11 2002 1531 1543 (Pubitemid 36020003)
53. T.J. Key, A. Schatzkin, W.C. Willett, N.E. Allen, E.A. Spencer, and R.C. Travis Diet, nutrition and the prevention of cancer Public Health Nutr. 7 2004 187 200 (Pubitemid 38294517)
54. A. Bergstrom, P. Pisani, V. Tenet, A. Wolk, and H.O. Adami Overweight as an avoidable cause of cancer in Europe Int. J. Cancer 91 2001 421 430 (Pubitemid 32049639)
55. P.T. Campbell, E.T. Jacobs, C.M. Ulrich, J.C. Figueiredo, J.N. Poynter, J.R. McLaughlin, R.W. Haile, E.J. Jacobs, P.A. Newcomb, J.D. Potter, L. Le Marchand, R.C. Green, P. Parfrey, H.B. Younghusband, M. Cotterchio, S. Gallinger, M.A. Jenkins, J.L. Hopper, J.A. Baron, S.N. Thibodeau, N.M. Lindor, P.J. Limburg, and M.E. Martinez Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status J. Natl Cancer Inst. 102 2010 391 400
56. E. Giovannucci, A. Ascherio, E.B. Rimm, G.A. Colditz, M.J. Stampfer, and W.C. Willett Physical activity, obesity, and risk for colon cancer and adenoma in men Ann. Intern. Med. 122 1995 327 334
57. T. Pischon, P.H. Lahmann, H. Boeing, A. Tjonneland, J. Halkjaer, K. Overvad, K. Klipstein-Grobusch, J. Linseisen, N. Becker, A. Trichopoulou, V. Benetou, D. Trichopoulos, S. Sieri, D. Palli, R. Tumino, P. Vineis, S. Panico, E. Monninkhof, P.H. Peeters, H.B. Bueno-de-Mesquita, F.L. Buchner, B. Ljungberg, G. Hallmans, G. Berglund, C.A. Gonzalez, M. Dorronsoro, A.B. Gurrea, C. Navarro, C. Martinez, J.R. Quiros, A. Roddam, N. Allen, S. Bingham, K.T. Khaw, R. Kaaks, T. Norat, N. Slimani, and E. Riboli Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) Int. J. Cancer 118 2006 728 738 (Pubitemid 43076024)
58. S. Yamamoto, T. Nakagawa, Y. Matsushita, S. Kusano, T. Hayashi, M. Irokawa, T. Aoki, Y. Korogi, and T. Mizoue Visceral fat area and markers of insulin resistance in relation to colorectal neoplasia Diab. Care 33 2010 184 189
59. E.E. Calle, H.L. Miracle-McMahill, M.J. Thun, and C.W. Heath Jr. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women J. Natl Cancer Inst. 87 1995 517 523
60. J. Ferlay, P. Autier, M. Boniol, M. Heanue, M. Colombet, and P. Boyle Estimates of the cancer incidence and mortality in Europe in 2006 Ann. Oncol. 18 2007 581 592 (Pubitemid 46359643)
61. A.W. Hsing, L.C. Sakoda, and S. Chua Jr. Obesity, metabolic syndrome, and prostate cancer Am. J. Clin. Nutr. 86 2007 s843 857
62. R.J. MacInnis, and D.R. English Body size and composition and prostate cancer risk: systematic review and meta-regression analysis Cancer Causes Control 17 2006 989 1003 (Pubitemid 44290764)
63. E. Giovannucci, E.B. Rimm, Y. Liu, M. Leitzmann, K. Wu, M.J. Stampfer, and W.C. Willett Body mass index and risk of prostate cancer in U.S. health professionals J. Natl Cancer Inst. 95 2003 1240 1244 (Pubitemid 37069555)
64. W.H. Chow, W.J. Blot, T.L. Vaughan, H.A. Risch, M.D. Gammon, J.L. Stanford, R. Dubrow, J.B. Schoenberg, S.T. Mayne, D.C. Farrow, H. Ahsan, A.B. West, H. Rotterdam, S. Niwa, and J.F. Fraumeni Jr. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia J. Natl Cancer Inst. 90 1998 150 155 (Pubitemid 28114417)
65. A. Kubo, and D.A. Corley Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis Cancer Epidemiol. Biomark. Prev. 15 2006 872 878 (Pubitemid 43823511)
66. W.H. Chow, W.D. Finkle, J.K. McLaughlin, H. Frankl, H.K. Ziel, and J.F. Fraumeni Jr. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia Jama 274 1995 474 477
67. J. Lagergren, R. Bergstrom, A. Lindgren, and O. Nyren Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma N. Engl. J. Med. 340 1999 825 831 (Pubitemid 29142625)
68. H.B. El-Serag, and K.L. Rudolph Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2007 2557 2576 (Pubitemid 46890874)
69. A.I. Gomaa, S.A. Khan, M.B. Toledano, I. Waked, and S.D. Taylor-Robinson Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis World J. Gastroenterol. 14 2008 4300 4308
70. S. Nair, A. Mason, J. Eason, G. Loss, and R.P. Perrillo Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology 36 2002 150 155 (Pubitemid 34700772)
71. S.H. Caldwell, D.M. Crespo, H.S. Kang, and A.M. Al-Osaimi Obesity and hepatocellular carcinoma Gastroenterology 127 2004 S97 103
72. S. Yang, H.Z. Lin, J. Hwang, V.P. Chacko, and A.M. Diehl Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Res. 61 2001 5016 5023 (Pubitemid 32681529)
73. S.C. Larsson, N. Orsini, and A. Wolk Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies Int. J. Cancer 120 2007 1993 1998 (Pubitemid 46418379)
74. S.C. Larsson, J. Permert, N. Hakansson, I. Naslund, L. Bergkvist, and A. Wolk Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts Br. J. Cancer 93 2005 1310 1315 (Pubitemid 41679420)
75. P.J. Sinner, K.H. Schmitz, K.E. Anderson, and A.R. Folsom Lack of association of physical activity and obesity with incident pancreatic cancer in elderly women Cancer Epidemiol. Biomark. Prev. 14 2005 1571 1573 (Pubitemid 40807365)
76. E.V. Bandera, L.H. Kushi, and L. Rodriguez-Rodriguez Nutritional factors in ovarian cancer survival Nutr. Cancer 61 2009 580 586
77. A. Wolk, G. Gridley, M. Svensson, O. Nyren, J.K. McLaughlin, J.F. Fraumeni, and H.O. Adam A prospective study of obesity and cancer risk (Sweden) Cancer Causes Control 12 2001 13 21 (Pubitemid 32125897)
78. R.C. van Kruijsdijk, E. van der Wall, and F.L. Visseren Obesity and cancer: the role of dysfunctional adipose tissue Cancer Epidemiol. Biomark. Prev. 18 2009 2569 2578
79. C. Bing, and P. Trayhurn New insights into adipose tissue atrophy in cancer cachexia Proc. Nutr. Soc. 68 2009 385 392
80. P.E. Scherer Adipose tissue: from lipid storage compartment to endocrine organ Diabetes 55 2006 1537 1545 (Pubitemid 44324105)
81. L. Baglietto, D.R. English, J.L. Hopper, R.J. MacInnis, H.A. Morris, W.D. Tilley, K. Krishnan, and G.G. Giles Circulating steroid hormone concentrations in postmenopausal women in relation to body size and composition Breast Cancer Res. Treat. 115 2009 171 179
82. P. Irigaray, J.A. Newby, S. Lacomme, and D. Belpomme Overweight/obesity and cancer genesis: more than a biological link Biomed. Pharmacother. 61 2007 665 678 (Pubitemid 350236686)
83. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867 (Pubitemid 36019639)
84. S.I. Grivennikov, F.R. Greten, and M. Karin Immunity, inflammation, and cancer Cell 140 2010 883 899
85. D. Wang, and R.N. Dubois Eicosanoids and cancer Nat. Rev. Cancer 10 2010 181 193
86. M.J. Moreno-Aliaga, J. Campion, F.I. Milagro, A. Berjón, and J.A. Martínez Adiposity and proinflammatory state: the chicken or the egg Adipocytes 1 2005 1 13
87. A. Maccio, C. Madeddu, and G. Mantovani Adipose tissue as target organ in the treatment of hormone-dependent breast cancer: new therapeutic perspectives Obes. Rev. 10 2009 660 670
88. E.E. Kershaw, and J.S. Flier Adipose tissue as an endocrine organ J. Clin. Endocrinol. Metab. 89 2004 2548 2556 (Pubitemid 38766330)
89. I.C. Park, M.J. Park, T.B. Choe, J.J. Jang, S.I. Hong, and S.H. Lee TNF-alpha induces apoptosis mediated by AEBSF-sensitive serine protease(s) that may involve upstream caspase-3/CPP32 protease activation in a human gastric cancer cell line Int. J. Oncol. 16 2000 1243 1248
90. H. Kulbe, R. Thompson, J.L. Wilson, S. Robinson, T. Hagemann, R. Fatah, D. Gould, A. Ayhan, and F. Balkwill The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells Cancer Res. 67 2007 585 592 (Pubitemid 46192196)
91. Y. Tomita, X. Yang, Y. Ishida, Y. Nemoto-Sasaki, T. Kondo, M. Oda, G. Watanabe, G.N. Chaldakov, C. Fujii, and N. Mukaida Spontaneous regression of lung metastasis in the absence of tumor necrosis factor receptor p55 Int. J. Cancer 112 2004 927 933 (Pubitemid 39506997)
92. F. Balkwill Tumour necrosis factor and cancer Nat. Rev. Cancer 9 2009 361 371
93. T. Hagemann, J. Wilson, H. Kulbe, N.F. Li, D.A. Leinster, K. Charles, F. Klemm, T. Pukrop, C. Binder, and F.R. Balkwill Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK J. Immunol. 175 2005 1197 1205 (Pubitemid 41095008)
94. Y. Wu, and B.P. Zhou TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion Br. J. Cancer 102 2010 639 644
95. H. Lu, W. Ouyang, and C. Huang Inflammation, a key event in cancer development Mol. Cancer Res. 4 2006 221 233
96. C.G. Li, M.L. Li, X.H. Shu, Y.J. Liu, and W.S. Wu Antitumor effects of recombinant human Interleukin-6 on mouse bladder carcinoma through Fas-mediated apoptosis Cancer Chemother. Pharmacol. 66 2010 981 986
97. D.R. Hodge, E.M. Hurt, and W.L. Farrar The role of IL-6 and STAT3 in inflammation and cancer Eur. J. Cancer 41 2005 2502 2512 (Pubitemid 41540626)
98. M.J. Moreno-Aliaga, S. Lorente-Cebrián, and J.A. Martinez Sesion 3: fatty acids and the immune system. Regulation of adipokine secretion by n-3 fatty acids Proc. Nutr. Soc. 69 2010 1 9
99. T. Kadowaki, and T. Yamauchi Adiponectin and adiponectin receptors Endocr. Rev. 26 2005 439 451 (Pubitemid 40686653)
100. A. Schaffler, J. Scholmerich, and C. Buechler Mechanisms of disease: adipokines and breast cancer-endocrine and paracrine mechanisms that connect adiposity and breast cancer Nat. Clin. Pract. Endocrinol. Metab. 3 2007 345 354 (Pubitemid 46474652)
101. C. Mantzoros, E. Petridou, N. Dessypris, C. Chavelas, M. Dalamaga, D.M. Alexe, Y. Papadiamantis, C. Markopoulos, E. Spanos, G. Chrousos, and D. Trichopoulos Adiponectin and breast cancer risk J. Clin. Endocrinol. Metab. 89 2004 1102 1107 (Pubitemid 38368397)
102. Y. Miyoshi, T. Funahashi, S. Kihara, T. Taguchi, Y. Tamaki, Y. Matsuzawa, and S. Noguchi Association of serum adiponectin levels with breast cancer risk Clin. Cancer Res. 9 2003 5699 5704 (Pubitemid 37499493)
103. J.H. Kang, Y.Y. Lee, B.Y. Yu, B.S. Yang, K.H. Cho, D.K. Yoon, and Y.K. Roh Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell Arch. Pharm. Res. 28 2005 1263 1269
104. E. Brakenhielm, N. Veitonmaki, R. Cao, S. Kihara, Y. Matsuzawa, B. Zhivotovsky, T. Funahashi, and Y. Cao Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis Proc. Natl Acad. Sci. USA 101 2004 2476 2481 (Pubitemid 38269336)
105. Z. Luo, M. Zang, and W. Guo AMPK as a metabolic tumor suppressor: control of metabolism and cell growth Future Oncol. 6 2010 457 470
106. H. Tilg, and A.R. Moschen Adipocytokines: mediators linking adipose tissue, inflammation and immunity Nat. Rev. Immunol. 6 2006 772 783 (Pubitemid 44453463)
107. B. De Taeye, L.H. Smith, and D.E. Vaughan Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease Curr. Opin. Pharmacol. 5 2005 149 154 (Pubitemid 40378745)
108. K. Dass, A. Ahmad, A.S. Azmi, S.H. Sarkar, and F.H. Sarkar Evolving role of uPA/uPAR system in human cancers Cancer Treat. Rev. 34 2008 122 136
109. J.C. Carter, and F.C. Church Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-gamma and plasminogen activator inhibitor-1 PPAR Res. 2009 2009 345320
110. H.C. Kwaan, J. Wang, K. Svoboda, and P.J. Declerck Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis Br. J. Cancer 82 2000 1702 1708 (Pubitemid 30229582)
111. A. Fukuhara, M. Matsuda, M. Nishizawa, K. Segawa, M. Tanaka, K. Kishimoto, Y. Matsuki, M. Murakami, T. Ichisaka, H. Murakami, E. Watanabe, T. Takagi, M. Akiyoshi, T. Ohtsubo, S. Kihara, S. Yamashita, M. Makishima, T. Funahashi, S. Yamanaka, R. Hiramatsu, Y. Matsuzawa, and I. Shimomura Visfatin: a protein secreted by visceral fat that mimics the effects of insulin Science 307 2005 426 430 (Pubitemid 40139988)
112. B. Samal, Y. Sun, G. Stearns, C. Xie, S. Suggs, and I. McNiece Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor Mol. Cell. Biol. 14 1994 1431 1437
113. J.R. Revollo, A.A. Grimm, and S. Imai The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals Curr. Opin. Gastroenterol. 23 2007 164 170 (Pubitemid 46192971)
114. T.D. Filippatos, C.S. Derdemezis, D.N. Kiortsis, A.D. Tselepis, and M.S. Elisaf Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome J. Endocrinol. Invest. 30 2007 323 326 (Pubitemid 47008083)
115. N.P. Kadoglou, A. Gkontopoulos, A. Kapelouzou, G. Fotiadis, E.K. Theofilogiannakos, G. Kottas, and S. Lampropoulos Serum levels of vaspin and visfatin in patients with coronary artery disease-Kozani study Clin. Chim. Acta 412 2011 48 52
116. C. Pagano, C. Pilon, M. Olivieri, P. Mason, R. Fabris, R. Serra, G. Milan, M. Rossato, G. Federspil, and R. Vettor Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans J. Clin. Endocrinol. Metab. 91 2006 3165 3170 (Pubitemid 44271773)
117. P. Wang, M.M. van Greevenbroek, F.G. Bouwman, M.C. Brouwers, C.J. van der Kallen, E. Smit, J. Keijer, and E.C. Mariman The circulating PBEF/NAMPT/visfatin level is associated with a beneficial blood lipid profile Pflugers Arch. 454 2007 971 976 (Pubitemid 47338462)
118. N. Perez-Echarri, P. Perez-Matute, B. Marcos-Gomez, J.A. Martinez, and M.J. Moreno-Aliaga Effects of eicosapentaenoic acid ethyl ester on visfatin and apelin in lean and overweight (cafeteria diet-fed) rats Br. J. Nutr. 101 2009 1059 1067
119. T.D. Filippatos, H.S. Randeva, C.S. Derdemezis, M.S. Elisaf, and D.P. Mikhailidis Visfatin/PBEF and atherosclerosis-related diseases Curr. Vasc. Pharmacol. 8 2010 12 28
120. T.Q. Bi, and X.M. Che Nampt/PBEF/visfatin and cancer Cancer Biol. Ther. 10 2010 119 125
121. S.T. Patel, T. Mistry, J.E. Brown, J.E. Digby, R. Adya, K.M. Desai, and H.S. Randeva A novel role for the adipokine visfatin/pre-B cell colony-enhancing factor 1 in prostate carcinogenesis Peptides 31 2010 51 57
122. B. Wang, M.K. Hasan, E. Alvarado, H. Yuan, H. Wu, W.Y. Chen, NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response, Oncogene 30 (2011) 907-921.
123. T.E. Nakajima, Y. Yamada, T. Hamano, K. Furuta, T. Gotoda, H. Katai, K. Kato, T. Hamaguchi, and Y. Shimada Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer J. Gastroenterol. 44 2009 685 690
124. J.G. Kim, E.O. Kim, B.R. Jeong, Y.J. Min, J.W. Park, E.S. Kim, I.S. Namgoong, Y.I. Kim, and B.J. Lee Visfatin stimulates proliferation of MCF-7 human breast cancer cells Mol. Cells 30 2010 341 345
125. M. Palou, J. Sanchez, A.M. Rodriguez, T. Priego, C. Pico, and A. Palou Induction of NPY/AgRP orexigenic peptide expression in rat hypothalamus is an early event in fasting: relationship with circulating leptin, insulin and glucose Cell. Physiol. Biochem. 23 2009 115 124
126. M.J. Lee, and S.K. Fried Integration of hormonal and nutrient signals that regulate leptin synthesis and secretion Am. J. Physiol. Endocrinol. Metab. 296 2009 E1230 1238
127. K. Lang, and J. Ratke Leptin and adiponectin: new players in the field of tumor cell and leukocyte migration Cell Commun. Signal. 7 2009 27
128. J.M. Howard, G.P. Pidgeon, and J.V. Reynolds Leptin and gastro-intestinal malignancies Obes. Rev. 11 2010 853 874
129. D. Cirillo, A.M. Rachiglio, R. la Montagna, A. Giordano, and N. Normanno Leptin signaling in breast cancer: an overview J. Cell. Biochem. 105 2008 956 964
130. H.S. Kim Leptin and leptin receptor expression in breast cancer Cancer Res. Treat. 41 2009 155 163
131. D. Housa, J. Housova, Z. Vernerova, and M. Haluzik Adipocytokines and cancer Physiol. Res. 55 2006 233 244
132. N.A. Binai, A. Damert, G. Carra, S. Steckelbroeck, J. Lower, R. Lower, and S. Wessler Expression of estrogen receptor alpha increases leptin-induced STAT3 activity in breast cancer cells Int. J. Cancer 127 2010 55 66
133. K.A. Frankenberry, H. Skinner, P. Somasundar, D.W. McFadden, and L.C. Vona-Davis Leptin receptor expression and cell signaling in breast cancer Int. J. Oncol. 28 2006 985 993
134. S. Catalano, S. Marsico, C. Giordano, L. Mauro, P. Rizza, M.L. Panno, and S. Ando Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line J. Biol. Chem. 278 2003 28668 28676 (Pubitemid 36935773)
135. H. Ren, T. Zhao, X. Wang, C. Gao, J. Wang, M. Yu, and J. Hao Leptin upregulates telomerase activity and transcription of human telomerase reverse transcriptase in MCF-7 breast cancer cells Biochem. Biophys. Res. Commun. 394 2010 59 63
136. R.R. Gonzalez-Perez, S. Guo, A. Watters, W. Zhou, and S.J. Leibovich Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFkappaB/HIF-1alpha activation Cell. Signal. 22 2010 1350 1362
137. E. Petridou, M. Belechri, N. Dessypris, P. Koukoulomatis, E. Diakomanolis, E. Spanos, and D. Trichopoulos Leptin and body mass index in relation to endometrial cancer risk Ann. Nutr. Metab. 46 2002 147 151 (Pubitemid 34920698)
138. S.S. Yuan, K.B. Tsai, Y.F. Chung, T.F. Chan, Y.T. Yeh, L.Y. Tsai, and J.H. Su Aberrant expression and possible involvement of the leptin receptor in endometrial cancer Gynecol. Oncol. 92 2004 769 775
139. J. Gao, J. Tian, Y. Lv, F. Shi, F. Kong, H. Shi, and L. Zhao Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells Cancer Sci. 100 2009 389 395
140. P. Stattin, A. Lukanova, C. Biessy, S. Soderberg, R. Palmqvist, R. Kaaks, T. Olsson, and E. Jellum Obesity and colon cancer: does leptin provide a link? Int. J. Cancer 109 2004 149 152 (Pubitemid 38160676)
141. R. Pais, H. Silaghi, A.C. Silaghi, M.L. Rusu, and D.L. Dumitrascu Metabolic syndrome and risk of subsequent colorectal cancer World J. Gastroenterol. 15 2009 5141 5148
142. J.C. Hardwick, G.R. Van Den Brink, G.J. Offerhaus, S.J. Van Deventer, and M.P. Peppelenbosch Leptin is a growth factor for colonic epithelial cells Gastroenterology 121 2001 79 90 (Pubitemid 32591517)
143. P. Rouet-Benzineb, T. Aparicio, S. Guilmeau, C. Pouzet, V. Descatoire, M. Buyse, and A. Bado Leptin counteracts sodium butyrate-induced apoptosis in human colon cancer HT-29 cells via NF-kappaB signaling J. Biol. Chem. 279 2004 16495 16502 (Pubitemid 38509348)
144. Z. Liu, T. Uesaka, H. Watanabe, and N. Kato High fat diet enhances colonic cell proliferation and carcinogenesis in rats by elevating serum leptin Int. J. Oncol. 19 2001 1009 1014
145. T. Aparicio, S. Guilmeau, H. Goiot, A. Tsocas, J.P. Laigneau, A. Bado, I. Sobhani, and T. Lehy Leptin reduces the development of the initial precancerous lesions induced by azoxymethane in the rat colonic mucosa Gastroenterology 126 2004 499 510 (Pubitemid 38182307)
146. T. Mistry, J.E. Digby, K.M. Desai, and H.S. Randeva Obesity and prostate cancer: a role for adipokines Eur. Urol. 52 2007 46 53 (Pubitemid 46803036)
147. C. Garofalo, and E. Surmacz Leptin and cancer J. Cell. Physiol. 207 2006 12 22
148. B.J. Kendall, G.A. Macdonald, N.K. Hayward, J.B. Prins, I. Brown, N. Walker, N. Pandeya, A.C. Green, P.M. Webb, and D.C. Whiteman Leptin and the risk of Barrett's oesophagus Gut 57 2008 448 454 (Pubitemid 351442525)
149. F. Francois, J. Roper, A.J. Goodman, Z. Pei, M. Ghumman, M. Mourad, A.Z. de Perez, G.I. Perez-Perez, C.H. Tseng, and M.J. Blaser The association of gastric leptin with oesophageal inflammation and metaplasia Gut 57 2008 16 24
150. S. Yakar, D. Leroith, and P. Brodt The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: lessons from animal models Cytokine Growth Factor Rev. 16 2005 407 420 (Pubitemid 41022011)
151. M.N. Pollak, E.S. Schernhammer, and S.E. Hankinson Insulin-like growth factors and neoplasia Nat. Rev. Cancer 4 2004 505 518 (Pubitemid 38868620)
152. S. Furukawa, T. Fujita, M. Shimabukuro, M. Iwaki, Y. Yamada, Y. Nakajima, O. Nakayama, M. Makishima, M. Matsuda, and I. Shimomura Increased oxidative stress in obesity and its impact on metabolic syndrome J. Clin. Invest. 114 2004 1752 1761 (Pubitemid 40385531)
153. K. Lim, C. Han, Y. Dai, M. Shen, and T. Wu Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2 Mol. Cancer Ther. 8 2009 3046 3055
154. M. Kamigaki, S. Sakaue, I. Tsujino, H. Ohira, D. Ikeda, N. Itoh, S. Ishimaru, Y. Ohtsuka, and M. Nishimura Oxidative stress provokes atherogenic changes in adipokine gene expression in 3T3-L1 adipocytes Biochem. Biophys. Res. Commun. 339 2006 624 632 (Pubitemid 41739713)
155. A.F. Soares, M. Guichardant, D. Cozzone, N. Bernoud-Hubac, N. Bouzaidi-Tiali, M. Lagarde, and A. Geloen Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes Free Radic. Biol. Med. 38 2005 882 889 (Pubitemid 40321080)
156. B. Halliwell Biochemistry of oxidative stress Biochem. Soc. Trans. 35 2007 1147 1150
157. R.H. Engel, and A.M. Evens Oxidative stress and apoptosis: a new treatment paradigm in cancer Front. Biosci. 11 2006 300 312 (Pubitemid 43253493)
158. D. Schafer, B. Hamm-Kunzelmann, and K. Brand Glucose regulates the promoter activity of aldolase A and pyruvate kinase M2 via dephosphorylation of Sp1 FEBS Lett. 417 1997 325 328 (Pubitemid 27511614)
159. F. Moukdar, J. Robidoux, O. Lyght, J. Pi, K.W. Daniel, and S. Collins Reduced antioxidant capacity and diet-induced atherosclerosis in uncoupling protein-2-deficient mice J. Lipid Res. 50 2009 59 70
160. M. Horimoto, P. Fulop, Z. Derdak, J.R. Wands, and G. Baffy Uncoupling protein-2 deficiency promotes oxidant stress and delays liver regeneration in
161. G. Baffy Uncoupling protein-2 and cancer Mitochondrion 10 2010 243 252
162. B. Cannon, I.G. Shabalina, T.V. Kramarova, N. Petrovic, and J. Nedergaard Uncoupling proteins: a role in protection against reactive oxygen species-or not? Biochim. Biophys. Acta 1757 2006 449 458 (Pubitemid 43993875)
163. J.X. Rong, Y. Qiu, M.K. Hansen, L. Zhu, V. Zhang, M. Xie, Y. Okamoto, M.D. Mattie, H. Higashiyama, S. Asano, J.C. Strum, and T.E. Ryan Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone Diabetes 56 2007 1751 1760 (Pubitemid 47025441)
164. L.N. Sutherland, L.C. Capozzi, N.J. Turchinsky, R.C. Bell, and D.C. Wright Time course of high-fat diet-induced reductions in adipose tissue mitochondrial proteins: potential mechanisms and the relationship to glucose intolerance Am. J. Physiol. Endocrinol. Metab. 295 2008 E1076 1083
165. D.P. Kelly, and R.C. Scarpulla Transcriptional regulatory circuits controlling mitochondrial biogenesis and function Genes Dev. 18 2004 357 368 (Pubitemid 38316342)
166. R.K. Semple, V.C. Crowley, C.P. Sewter, M. Laudes, C. Christodoulides, R.V. Considine, A. Vidal-Puig, and S. O'Rahilly Expression of the thermogenic nuclear hormone receptor coactivator PGC-1alpha is reduced in the adipose tissue of morbidly obese subjects Int. J. Obes. Relat. Metab. Disord. 28 2004 176 179 (Pubitemid 38142007)
167. S. Costa Cdos, T.O. Hammes, F. Rohden, R. Margis, J.W. Bortolotto, A.V. Padoin, C.C. Mottin, and R.M. Guaragna SIRT1 transcription is decreased in visceral adipose tissue of morbidly obese patients with severe hepatic steatosis Obes. Surg. 20 2010 633 639
168. P. Perez-Matute, M.A. Zulet, and J.A. Martinez Reactive species and diabetes: counteracting oxidative stress to improve health Curr. Opin. Pharmacol. 9 2009 771 779
169. I. Bogacka, B. Ukropcova, M. McNeil, J.M. Gimble, and S.R. Smith Structural and functional consequences of mitochondrial biogenesis in human adipocytes in vitro J. Clin. Endocrinol. Metab. 90 2005 6650 6656 (Pubitemid 41759328)
170. A.E. Civitarese, S.R. Smith, and E. Ravussin Diet, energy metabolism and mitochondrial biogenesis Curr. Opin. Clin. Nutr. Metab. Care 10 2007 679 687 (Pubitemid 350293767)
171. K.A. Rasbach, and R.G. Schnellmann Isoflavones promote mitochondrial biogenesis J. Pharmacol. Exp. Ther. 325 2008 536 543 (Pubitemid 351574800)
172. C. Junien, and C. Gallou Cancer nutrigenomics World Rev. Nutr. Diet. 93 2004 210 269
173. C.D. Davis, and J. Milner Frontiers in nutrigenomics, proteomics, metabolomics and cancer prevention Mutat. Res. 551 2004 51 64 (Pubitemid 38842421)
174. J.M. Ordovas, and V. Mooser Nutrigenomics and nutrigenetics Curr. Opin. Lipidol. 15 2004 101 108 (Pubitemid 38453397)
175. M. Fenech, C. Aitken, and J. Rinaldi Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults Carcinogenesis 19 1998 1163 1171 (Pubitemid 28375365)
176. M. Muller, and S. Kersten Nutrigenomics: goals and strategies Nat. Rev. Genet. 4 2003 315 322 (Pubitemid 36389536)
177. D. American Institute for Cancer Research Washington, World Cancer Research Fund, American Institute for Cancer Research, Food, Nutrition and the Prevention on Cancer: A global Perspective 1997.
178. Y.J. Surh Cancer chemoprevention with dietary phytochemicals Nat. Rev. Cancer 3 2003 768 780
179. E. Escrich, R. Moral, L. Grau, I. Costa, and M. Solanas Molecular mechanisms of the effects of olive oil and other dietary lipids on cancer Mol. Nutr. Food Res. 51 2007 1279 1292 (Pubitemid 350013175)
180. A. Esfahani, J.M. Wong, A. Mirrahimi, K. Srichaikul, D.J. Jenkins, and C.W. Kendall The glycemic index: physiological significance J. Am. Coll. Nutr. 28 2009 439S 445S
181. H. Bartsch, J. Nair, and R.W. Owen Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers Carcinogenesis 20 1999 2209 2218 (Pubitemid 30015890)
182. L.N. Kolonel, A.M. Nomura, and R.V. Cooney Dietary fat and prostate cancer: current status J. Natl Cancer Inst. 91 1999 414 428 (Pubitemid 29128277)
183. L. Kushi, and E. Giovannucci Dietary fat and cancer Am. J. Med. 113 Suppl 9B 2002 63S 70S (Pubitemid 36151833)
184. O.S. Lin Acquired risk factors for colorectal cancer Meth. Mol. Biol. 472 2009 361 372
185. G.A. Bray, J.C. Lovejoy, S.R. Smith, J.P. DeLany, M. Lefevre, D. Hwang, D.H. Ryan, and D.A. York The influence of different fats and fatty acids on obesity, insulin resistance and inflammation J. Nutr. 132 2002 2488 2491 (Pubitemid 35013224)
186. A. Astrup The role of dietary fat in obesity Semin. Vasc. Med. 5 2005 40 47 (Pubitemid 40721044)
187. C.A. Thomson, and P.A. Thompson Dietary patterns, risk and prognosis of breast cancer Future Oncol. 5 2009 1257 1269
188. P. Perez-Matute, A. Marti, J.A. Martinez, M.P. Fernandez-Otero, K.L. Stanhope, P.J. Havel, and M.J. Moreno-Aliaga Eicosapentaenoic fatty acid increases leptin secretion from primary cultured rat adipocytes: role of glucose metabolism Am. J. Physiol. Regul. Integr. Comp. Physiol. 288 2005 R1682 1688
189. C.N. Serhan, S. Hong, K. Gronert, S.P. Colgan, P.R. Devchand, G. Mirick, and R.L. Moussignac Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals J. Exp. Med. 196 2002 1025 1037 (Pubitemid 35231761)
190. S. Lorente-Cebrian, M. Bustos, A. Marti, J.A. Martinez, and M.J. Moreno-Aliaga Eicosapentaenoic acid stimulates AMP-activated protein kinase and increases visfatin secretion in cultured murine adipocytes Clin. Sci. Lond. 117 2009 243 249
191. J. Kopecky, M. Rossmeisl, P. Flachs, O. Kuda, P. Brauner, Z. Jilkova, B. Stankova, E. Tvrzicka, and M. Bryhn n-3 PUFA: bioavailability and modulation of adipose tissue function Proc. Nutr. Soc. 68 2009 361 369
192. A. Gonzalez-Periz, R. Horrillo, N. Ferre, K. Gronert, B. Dong, E. Moran-Salvador, E. Titos, M. Martinez-Clemente, M. Lopez-Parra, V. Arroyo, and J. Claria Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins FASEB J. 23 2009 1946 1957
193. P. Flachs, O. Horakova, P. Brauner, M. Rossmeisl, P. Pecina, N. Franssen-van Hal, J. Ruzickova, J. Sponarova, Z. Drahota, C. Vlcek, J. Keijer, J. Houstek, and J. Kopecky Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat Diabetologia 48 2005 2365 2375 (Pubitemid 41618929)
194. P. Perez-Matute, N. Perez-Echarri, J.A. Martinez, A. Marti, and M.J. Moreno-Aliaga Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: role of apoptosis, adiponectin and tumour necrosis factor-alpha Br. J. Nutr. 97 2007 389 398 (Pubitemid 46671814)
195. S. Lorente-Cebrian, P. Perez-Matute, J.A. Martinez, A. Marti, and M.J. Moreno-Aliaga Effects of eicosapentaenoic acid (EPA) on adiponectin gene expression and secretion in primary cultured rat adipocytes J. Physiol. Biochem. 62 2006 61 69
196. M. Itoh, T. Suganami, N. Satoh, K. Tanimoto-Koyama, X. Yuan, M. Tanaka, H. Kawano, T. Yano, S. Aoe, M. Takeya, A. Shimatsu, H. Kuzuya, Y. Kamei, and Y. Ogawa Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects Arterioscler. Thromb. Vasc. Biol. 27 2007 1918 1925 (Pubitemid 47315642)
197. S. Lorente-Cebrian, M. Bustos, A. Marti, J.A. Martinez, and M.J. Moreno-Aliaga Eicosapentaenoic acid up-regulates apelin secretion and gene expression in 3T3-L1 adipocytes Mol. Nutr. Food Res. 54 Suppl 1 2010 S104 111
198. K.S. Kang, P. Wang, N. Yamabe, M. Fukui, T. Jay, and B.T. Zhu Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation PLoS ONE 5 2010 e10296
199. N.B. Janakiram, and C.V. Rao Role of lipoxins and resolvins as anti-inflammatory and proresolving mediators in colon cancer Curr. Mol. Med. 9 2009 565 579
200. Y.L. Ha, N.K. Grimm, and M.W. Pariza Anticarcinogens from fried ground beef: heat-altered derivatives of linoleic acid Carcinogenesis 8 1987 1881 1887 (Pubitemid 17163950)
201. A. Kennedy, K. Martinez, S. Schmidt, S. Mandrup, K. LaPoint, and M. McIntosh Antiobesity mechanisms of action of conjugated linoleic acid J. Nutr. Biochem. 21 2010 171 179
202. N.M. Racine, A.C. Watras, A.L. Carrel, D.B. Allen, J.J. McVean, R.R. Clark, A.R. O'Brien, M. O'Shea, C.E. Scott, and D.A. Schoeller Effect of conjugated linoleic acid on body fat accretion in overweight or obese children Am. J. Clin. Nutr. 91 2010 1157 1164
203. A. Ohashi, Y. Matsushita, K. Kimura, K. Miyashita, and M. Saito Conjugated linoleic acid deteriorates insulin resistance in obese/diabetic mice in association with decreased production of adiponectin and leptin J. Nutr. Sci. Vitaminol. (Tokyo) 50 2004 416 421
204. P. Perez-Matute, A. Marti, J.A. Martinez, M.P. Fernandez-Otero, K.L. Stanhope, P.J. Havel, and M.J. Moreno-Aliaga Conjugated linoleic acid inhibits glucose metabolism, leptin and adiponectin secretion in primary cultured rat adipocytes Mol. Cell. Endocrinol. 268 2007 50 58 (Pubitemid 46428475)
205. Y.C. Hsu, X. Meng, L. Ou, and M.M. Ip Activation of the AMP-activated protein kinase-p38 MAP kinase pathway mediates apoptosis induced by conjugated linoleic acid in p53-mutant mouse mammary tumor cells Cell. Signal. 22 2010 590 599
206. D.S. Lau, and M.C. Archer The 10t, 12c isomer of conjugated linoleic acid inhibits fatty acid synthase expression and enzyme activity in human breast, colon, and prostate cancer cells Nutr. Cancer 62 2010 116 121
207. H.K. Vincent, K.E. Innes, and K.R. Vincent Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity Diab. Obes. Metab. 9 2007 813 839 (Pubitemid 47555204)
208. A.B. Crujeiras, M.D. Parra, M.C. Rodriguez, B.E. Martinez de Morentin, and J.A. Martinez A role for fruit content in energy-restricted diets in improving antioxidant status in obese women during weight loss Nutrition 22 2006 593 599
209. C. Bisbal, K. Lambert, and A. Avignon Antioxidants and glucose metabolism disorders Curr. Opin. Clin. Nutr. Metab. Care 13 2010 439 446
210. W.J. Blot, J.Y. Li, P.R. Taylor, W. Guo, S. Dawsey, G.Q. Wang, C.S. Yang, S.F. Zheng, M. Gail, and G.Y. Li Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population J. Natl Cancer Inst. 85 1993 1483 1492 (Pubitemid 23269183)
211. C.H. Hennekens, J.E. Buring, J.E. Manson, M. Stampfer, B. Rosner, N.R. Cook, C. Belanger, F. LaMotte, J.M. Gaziano, P.M. Ridker, W. Willett, and R. Peto Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease N. Engl. J. Med. 334 1996 1145 1149 (Pubitemid 26137972)
212. I.M. Lee Antioxidant vitamins in the prevention of cancer Proc. Assoc. Am. Physicians 111 1999 10 15
213. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group N. Engl. J. Med. 330 1994 1029 1035
214. G.S. Omenn, G.E. Goodman, M.D. Thornquist, J. Balmes, M.R. Cullen, A. Glass, J.P. Keogh, F.L. Meyskens, B. Valanis, J.H. Williams, S. Barnhart, and S. Hammar Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease N. Engl. J. Med. 334 1996 1150 1155 (Pubitemid 26137973)
215. J. Verrax, and P.B. Calderon The controversial place of vitamin C in cancer treatment Biochem. Pharmacol. 76 2008 1644 1652
216. L.M. Hung, J.K. Chen, S.S. Huang, R.S. Lee, and M.J. Su Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes Cardiovasc. Res. 47 2000 549 555
217. J. Vanamala, L. Reddivari, S. Radhakrishnan, and C. Tarver Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways BMC Cancer 10 2010 238
218. C.A. de la Lastra, and I. Villegas Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications Biochem. Soc. Trans. 35 2007 1156 1160 (Pubitemid 350206449)
219. M.T. Macarulla, G. Alberdi, S. Gomez, I. Tueros, C. Bald, V.M. Rodriguez, J.A. Martinez, and M.P. Portillo Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric diet J. Physiol. Biochem. 65 2009 369 376
220. M.C. Aubin, C. Lajoie, R. Clement, H. Gosselin, A. Calderone, and L.P. Perrault Female rats fed a high-fat diet were associated with vascular dysfunction and cardiac fibrosis in the absence of overt obesity and hyperlipidemia: therapeutic potential of resveratrol J. Pharmacol. Exp. Ther. 325 2008 961 968 (Pubitemid 351724317)
221. K. Szkudelska, and T. Szkudelski Resveratrol, obesity and diabetes Eur. J. Pharmacol. 635 2010 1 8
222. P. Fischer-Posovszky, V. Kukulus, D. Tews, T. Unterkircher, K.M. Debatin, S. Fulda, and M. Wabitsch Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner Am. J. Clin. Nutr. 92 2010 5 15
223. K. Szkudelska, L. Nogowski, and T. Szkudelski The inhibitory effect of resveratrol on leptin secretion from rat adipocytes Eur. J. Clin. Invest. 39 2009 899 905
224. J.A. Baur, K.J. Pearson, N.L. Price, H.A. Jamieson, C. Lerin, A. Kalra, V.V. Prabhu, J.S. Allard, G. Lopez-Lluch, K. Lewis, P.J. Pistell, S. Poosala, K.G. Becker, O. Boss, D. Gwinn, M. Wang, S. Ramaswamy, K.W. Fishbein, R.G. Spencer, E.G. Lakatta, D. Le Couteur, R.J. Shaw, P. Navas, P. Puigserver, D.K. Ingram, R. de Cabo, and D.A. Sinclair Resveratrol improves health and survival of mice on a high-calorie diet Nature 444 2006 337 342 (Pubitemid 44764104)
225. J.H. Um, S.J. Park, H. Kang, S. Yang, M. Foretz, M.W. McBurney, M.K. Kim, B. Viollet, and J.H. Chung AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol Diabetes 59 2010 554 563
226. J.N. Feige, M. Lagouge, C. Canto, A. Strehle, S.M. Houten, J.C. Milne, P.D. Lambert, C. Mataki, P.J. Elliott, and J. Auwerx Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation Cell Metab. 8 2008 347 358
227. J.N. Lin, V.C. Lin, K.M. Rau, P.C. Shieh, D.H. Kuo, J.C. Shieh, W.J. Chen, S.C. Tsai, and T.D. Way Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation J. Agric. Food Chem. 58 2010 1584 1592
228. A. Bishayee Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials Cancer Prev. Res. (Phila Pa.) 2 2009 409 418
229. K.P. Shay, R.F. Moreau, E.J. Smith, A.R. Smith, and T.M. Hagen Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential Biochim. Biophys. Acta 1790 2009 1149 1160
230. L. Packer, and Y.J. Suzuki Vitamin E and alpha-lipoate: role in antioxidant recycling and activation of the NF-kappa B transcription factor Mol. Aspects Med. 14 1993 229 239
231. I. Padmalayam, S. Hasham, U. Saxena, and S. Pillarisetti Lipoic acid synthase (LASY): a novel role in inflammation, mitochondrial function, and insulin resistance Diabetes 58 2009 600 608
232. L. Packer, E.H. Witt, and H.J. Tritschler alpha-Lipoic acid as a biological antioxidant Free Radic. Biol. Med. 19 1995 227 250
233. A. Bilska, and L. Wlodek Lipoic acid-the drug of the future? Pharmacol. Rep. 57 2005 570 577
234. M.S. Kim, J.Y. Park, C. Namkoong, P.G. Jang, J.W. Ryu, H.S. Song, J.Y. Yun, I.S. Namgoong, J. Ha, I.S. Park, I.K. Lee, B. Viollet, J.H. Youn, H.K. Lee, and K.U. Lee Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase Nat. Med. 10 2004 727 733 (Pubitemid 38937638)
235. P.L. Prieto-Hontoria, P. Perez-Matute, M. Fernandez-Galilea, A. Barber, J.A. Martinez, and M.J. Moreno-Aliaga Lipoic acid prevents body weight gain induced by a high fat diet in rats: effects on intestinal sugar transport J. Physiol. Biochem. 65 2009 43 50
236. M.G. Carbonelli, L. Di Renzo, M. Bigioni, N. Di Daniele, A. De Lorenzo, and M.A. Fusco Alpha-lipoic acid supplementation: a tool for obesity therapy? Curr. Pharm. Des. 16 2010 840 846
237. Q.W. Shen, C.S. Jones, N. Kalchayanand, M.J. Zhu, and M. Du Effect of dietary alpha-lipoic acid on growth, body composition, muscle pH, and AMP-activated protein kinase phosphorylation in mice J. Anim. Sci. 83 2005 2611 2617
238. Y. Wang, X. Li, Y. Guo, L. Chan, and X. Guan alpha-Lipoic acid increases energy expenditure by enhancing adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor-gamma coactivator-1alpha signaling in the skeletal muscle of aged mice Metabolism 59 2010 967 976
239. K.G. Park, A.K. Min, E.H. Koh, H.S. Kim, M.O. Kim, H.S. Park, Y.D. Kim, T.S. Yoon, B.K. Jang, J.S. Hwang, J.B. Kim, H.S. Choi, J.Y. Park, I.K. Lee, and K.U. Lee Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways Hepatology 48 2008 1477 1486
240. W.J. Lee, K.H. Song, E.H. Koh, J.C. Won, H.S. Kim, H.S. Park, M.S. Kim, S.W. Kim, K.U. Lee, and J.Y. Park Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle Biochem. Biophys. Res. Commun. 332 2005 885 891
241. K.H. Song, W.J. Lee, J.M. Koh, H.S. Kim, J.Y. Youn, H.S. Park, E.H. Koh, M.S. Kim, J.H. Youn, K.U. Lee, and J.Y. Park alpha-Lipoic acid prevents diabetes mellitus in diabetes-prone obese rats Biochem. Biophys. Res. Commun. 326 2005 197 202 (Pubitemid 39573219)
242. W. Shen, J. Hao, C. Tian, J. Ren, L. Yang, X. Li, C. Luo, C.W. Cotma, and J. Liu A combination of nutriments improves mitochondrial biogenesis and function in skeletal muscle of type 2 diabetic Goto-Kakizaki rats PLoS ONE 3 2008 e2328
243. W. Shen, K. Liu, C. Tian, L. Yang, X. Li, J. Ren, L. Packer, C.W. Cotman, and J. Liu R-alpha-lipoic acid and acetyl-l-carnitine complementarily promote mitochondrial biogenesis in murine 3T3-L1 adipocytes Diabetologia 51 2008 165 174 (Pubitemid 50003767)
244. L. Novotny, P. Rauko, and C. Cojocel alpha-Lipoic acid: the potential for use in cancer therapy Neoplasma 55 2008 81 86
245. S.Y. Choi, J.H. Yu, and H. Kim Mechanism of alpha-lipoic acid-induced apoptosis of lung cancer cells Ann. NY Acad. Sci. 1171 2009 149 155
246. D.Y. Shi, H.L. Liu, J.S. Stern, P.Z. Yu, and S.L. Liu Alpha-lipoic acid induces apoptosis in hepatoma cells via the PTEN/Akt pathway FEBS Lett. 582 2008 1667 1671
247. J. Moungjaroen, U. Nimmannit, P.S. Callery, L. Wang, N. Azad, V. Lipipun, P. Chanvorachote, and Y. Rojanasakul Reactive oxygen species mediate caspase activation and apoptosis induced by lipoic acid in human lung epithelial cancer cells through Bcl-2 down-regulation J. Pharmacol. Exp. Ther. 319 2006 1062 1069
248. M.H. Na, E.Y. Seo, and W.K. Kim Effects of alpha-lipoic acid on cell proliferation and apoptosis in MDA-MB-231 human breast cells Nutr. Res. Pract. 3 2009 265 271